The import of Phenazone (Antipyrin) to the US is forecasted to slightly decline from 7.66, Thousand Kilograms in 2024, to 7.27, Thousand Kilograms by 2028. This reflects a subtle downward trend year-on-year with an approximate annual decrease of 1.3%. This gradual decline suggests a compound annual growth rate (CAGR) of approximately -1.3% over the five-year forecast period. For context, the import volume in 2023 was 7.76, Thousand Kilograms, indicating a continuation of this downward trend.

Future trends to watch for include:

Changes in global production levels and supply chain dynamics affecting import volumes.
Potential shifts in pharmaceutical demand within the US, impacting the need for Phenazone (Antipyrin).
Regulatory changes in the US or exporter countries that might alter trade flows.